Latest stories on MDCX
Medicus Pharma Receives Positive FDA Feedback and Central IRB Approval for Optimized Phase 2 Teverelix® Novel Study in Acute Urinary Retention
Business Insider67 · bullishproduct/pr
Is Medicus Pharma Ltd. (MDCX) Stock Gaining Momentum With Innovative Skin Cancer Treatment Technology?
Yahoo Top63 · neutralproduct/pr
New to The Street broadcasts show #758 TODAY AT 6:30 PM ET on BLOOMBERG TELEVISION ACROSS THE UNITED STATES, LATIN AMERICA, AND MENA
Business Insider50 · neutralgeneral
Pro Medicus Dropped from S&P/ASX 50 in June Index Shake-Up
TipRanks38 · neutralgeneral
Medicus Pharma Advances SkinJect® into Registrational Development for Gorlin Syndrome | MDCX Stock News
StockTitan67 · bullishproduct/pr
Medicus Pharma secures up to $22M in non-dilutive financing facility
Yahoo Finance63 · neutralgeneral
Medicus Pharma Announces $22 Million Non-Dilutive Financing | MDCX Stock News
StockTitan63 · neutralgeneral
Medicus Pharma Secures Financing Amid Nasdaq Compliance Pressure
TipRanks24 · bearishgeneral
Latest foreign investment in UK highlights underserved potential of primary care technology
Yahoo Top58 · neutralgeneral
EXCLUSIVE: Medicus Sees Strongest Efficacy At Higher Dose In Skin Cancer Study
Yahoo Top67 · bullishproduct/pr